Valacyclovir
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00577 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 22 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | rheumatoid arthritis | KG + DL |
| 2 | sclerosing cholangitis | KG + DL |
| 3 | colobomatous microphthalmia-rhizomelic dysplasia syndrome | KG + DL |
| 4 | brachydactyly-syndactyly syndrome | KG + DL |
| 5 | autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome | KG + DL |
| 6 | brain small vessel disease 1 with or without ocular anomalies | KG + DL |
| 7 | diabetic nephropathy | KG + DL |
| 8 | bronchitis | KG + DL |
| 9 | congestive heart failure | KG + DL |
| 10 | peripheral arterial disease | KG + DL |
| 11 | acute pulmonary heart disease | KG + DL |
| 12 | osteoarthritis susceptibility | KG + DL |
| 13 | trigeminal autonomic cephalalgia | KG + DL |
| 14 | chronic renal failure syndrome | KG + DL |
| 15 | laryngotracheitis | KG + DL |
| 16 | methemoglobinemia, alpha type | KG + DL |
| 17 | headache disorder | KG + DL |
| 18 | chronic kidney disease | KG + DL |
| 19 | Lyme disease | KG + DL |
| 20 | peripheral vascular disease | KG + DL |
| 21 | facial nerve palsy due to herpes zoster infection | KG + DL |
| 22 | methemoglobin reductase deficiency | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.